(Q39611554)

13 September 2017

title

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors (English)

1 reference

13 September 2017

1 reference

1 reference

8

1 reference

13 September 2017

Birgit Flechl

1

1 reference

13 September 2017

Michael Ackerl

2

1 reference

13 September 2017

Cornelia Sax

3

1 reference

13 September 2017

Karin Dieckmann

4

1 reference

13 September 2017

Richard Crevenna

5

1 reference

13 September 2017

Alexander Gaiger

6

1 reference

13 September 2017

Georg Widhalm

7

1 reference

13 September 2017

Christine Marosi

9

1 reference

13 September 2017

publication date

29 May 2012

1 reference

Journal of Neuro-Oncology

13 September 2017

published in

1 reference

13 September 2017

volume

109

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

331-339

1 reference

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Long-term survivors of glioblastoma: clinical features and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Current concepts and management of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Incidence of neurologic deficits and rehabilitation of patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Cognitive deficits in adult patients with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Neurological outcome of long-term glioblastoma survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

NeuroCog FX: computerized screening of cognitive functions in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Recording neurological impairment in clinical trials of glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Significant change in tests of neurological impairment in patients with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Review on quality of life issues in patients with primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Neurocognitive training in patients with high-grade glioma: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Early cognitive impairment in a subset of patients with presumed low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Psychometric- and quality-of-life assessment in long-term glioblastoma survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Surviving glioblastoma for more than 5 years: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0897-1

Neurocognitive and functional assessment of patients with brain metastases: a pilot study

21 January 2018

1 reference

12 December 2020

Which glioblastoma multiforme patient will become a long-term survivor? A population-based study

1 reference

12 December 2020

Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.

1 reference

12 December 2020

Glioblastoma multiforme with long term survival

1 reference

12 December 2020

Therapeutic irradiation and brain injury

1 reference

12 December 2020

10.1007/S11060-012-0897-1

Identifiers

DOI

1 reference

13 September 2017

1 reference